PROTECTED GUIDE RNAS (PGRNAS)
    5.
    发明申请

    公开(公告)号:US20220010339A1

    公开(公告)日:2022-01-13

    申请号:US17489308

    申请日:2021-09-29

    摘要: The invention provides for systems, methods, and compositions for altering expression of target gene sequences and related gene products. Provided are structural information on the Cas protein of the CRISPR-Cas system, use of this information in generating modified components of the CRISPR complex, vectors and vector systems which encode one or more components or modified components of a CRISPR complex, as well as methods for the design and use of such vectors and components. Also provided are methods of directing CRISPR complex formation in eukaryotic cells and methods for utilizing the CRISPR-Cas system. In particular the present invention comprehends optimized functional CRISPR-Cas enzyme systems, wherein the guide sequence is modified by secondary structure to increase the specificity of the CRISPR-Cas system and whereby the secondary structure can protect against exonuclease activity and allow for 5′ additions to the guide sequence.

    OPTIMIZED CRISPR-CAS DOUBLE NICKASE SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
    7.
    发明申请
    OPTIMIZED CRISPR-CAS DOUBLE NICKASE SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION 审中-公开
    优化CRISPR-CAS双重NICKASE系统,用于序列操作的方法和组合

    公开(公告)号:US20160153006A1

    公开(公告)日:2016-06-02

    申请号:US14972523

    申请日:2015-12-17

    摘要: The invention provides for delivery, engineering and optimization of systems, methods, and compositions for manipulation of sequences and/or activities of target sequences. Provided are vectors and vector systems, some of which encode one or more components of a CRISPR complex, as well as methods for the design and use of such vectors. Also provided are methods of directing CRISPR complex formation in prokaryotic and eukaryotic cells to ensure enhanced specificity for target recognition and avoidance of toxicity.

    摘要翻译: 本发明提供了用于操纵靶序列的序列和/或活性的系统,方法和组合物的递送,工程和优化。 提供了载体和载体系统,其中一些编码CRISPR复合物的一个或多个组分,以及用于设计和使用这种载体的方法。 还提供了在原核和真核细胞中引导CRISPR复合物形成的方法,以确保增强靶标识别和避免毒性的特异性。